Le Lézard
Classified in: Health, Business
Subjects: CON, FVT, MAT

Fire & Flower Announces Agreement to Acquire Retail Cannabis Store in North Battleford, Saskatchewan


EDMONTON, Oct. 16, 2018 /CNW/ - Independent corporate cannabis retailer Fire & Flower is pleased to announce that it has entered into binding agreement to acquire all of the issued and outstanding shares of 10945072 Canada Inc. ("North Battleford CannabisCo").  North Battleford CannabisCo has built and received approval to operate a licensed cannabis retail shop in North Battleford, Saskatchewan. The acquisition is conditional upon North Battleford CannabisCo commencing operations as a licenced cannabis retailer and receipt of all required approvals.  North Battleford CannabisCo has received advance authorization from the Saskatchewan Gaming, Liquor and Cannabis Authority to purchase and store cannabis and expects to commence operations on October 17, 2018. 

The transaction is expected to close on or about October 18, 2018, following which the shop will now operate under the Fire & Flower banner, delivering an exceptional customer experience and supplying expertly-curated Health Canada-regulated products in a bright and modern environment.  

"We are pleased to select Fire & Flower as the cannabis retailer of choice to continue the historic progress we have made with our licensed cannabis retail shop," said James R. Davey, President & CEO of North Battleford CannabisCo as well as Curativa Cannabis, a division of Envirosafe Chemicals Canada. "We are confident to entrust Fire & Flower's conscious philosophy and eloquent sophistication to provide cannabis to consumers in the community of North Battleford. This divestiture will allow us the opportunity to focus on our diversification into cannabis growth and production as a licenced producer." 

Like all Fire & Flower shops, the one in North Battleford will follow a robust security protocol to ensure the highest standards of safety for the community, including a two-step age verification process to prohibit purchases by minors, programs to promote road safety, and extensive community engagement.  

Fire & Flower is actively developing cannabis retail stores in Alberta and Saskatchewan to commence sales on October 17, 2018 and is pursuing additional opportunities to obtain cannabis retail licenses in Ontario, British Columbia and Manitoba.

The North Battleford shop is located at 2, 302 114th Street and will be open on Wednesday, October 17, 2018 10 AM ? 5 PM, where adults are invited to join Fire & Flower and for a Ribbon Cutting Ceremony at 10 AM. Thereafter, regular store hours will be Monday ? Saturday 10 AM ? 10 PM, and Sundays 11 AM ? 7 PM. For more information, check out the Fire & Flower website at fireandflower.com.   

About Fire & Flower 

Founded by experienced legal cannabis entrepreneurs from the federal system, Fire & Flower is a leading independent adult-use cannabis retailer poised to capture significant market share in Canadian provinces that allow private retail. The Company will provide customers with expertly curated product selection and a best-in-class, education-driven customer experience. 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION 
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as "forward-looking statements") within the meaning of applicable Canadian securities laws. All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "achieve", "could", "believe", "plan", "intend", "objective", "continuous", "ongoing", "estimate", "outlook", "expect", "may", "will", "project", "should" or similar words, including negatives thereof, suggesting future outcomes. Management of the Company believes the expectations reflected in such forward-looking statements are reasonable as of the date hereof but no assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon. Various material factors and assumptions are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking statements. Those material factors and assumptions are based on information currently available to the Company, including data from publicly available governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of the retail cannabis industry which the Company believes to be reasonable. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. While the Company is not aware of any misstatement regarding any industry or government data presented herein, the retail cannabis industry involves risks and uncertainties and is subject to change based on various factors. 

Forward-looking statements are not a guarantee of future performance and are subject to and involve a number of known and unknown risks and uncertainties, many of which are beyond the control of the Company, which may cause the Company's actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements.  

Any forward-looking statements are made as of the date hereof and, except as required by law, the Company assumes no obligation to publicly update or revise such statements to reflect new information, subsequent or otherwise.

SOURCE Fire & Flower Inc.


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: